In particular, IP-10 was present at much higher levels than MIG and I-TAC, was highest in those with TNBC disease, and its high expression also correlated significantly with shortened survival times in breast cancer patients with metastatic disease. This evidence concerns the gene CXCL9 and breast carcinoma.